A randomized clinical trial found that the antidepressant fluvoxamine significantly reduces long COVID-related fatigue, one of the condition’s most persistent and debilitating symptoms, while the diabetes drug metformin showed no benefit….
Continue Reading
News Source: medicalxpress.com
Leave a Reply